Elevation of urinary porphyrin levels following gemcitabine administration.
Daniele
B
B
De Vivo
R
R
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001650:Bile Duct Neoplasms / Q000188:drug therapy; D018281:Cholangiocarcinoma / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D011166:Porphyrins / Q000652:urine*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D011166:Porphyrins; D003841:Deoxycytidine; D000093542:Gemcitabine